J Clin Invest 125: 22932306 KaposiNovak P, Libbrecht L, Woo HG, Lee YH, Sears NC, Conner EA, Factor VM, Roskams T, Thorgeirsson SS (2009) Central role of cMyc during malignant conversion in human hepatocarcinogenesis
Urolithin A, a gut-derived metabolite of ellagic acid that activates mitophagy (the selective removal of damaged mitochondria), pairs logically with MOTS-c because the two address different aspects of mitochondrial health
Precursors Glutathione is quite useful, but it is a sensitive nutrient
Does KPV peptide require a prescription for research use
However, like all treatments, they can have side effects